CME Group Earnings Calls

Mar 31, 2026
$3.36 (0.599%)
Release date Apr 22, 2026
EPS estimate $3.34
EPS actual $3.36
EPS Surprise 0.599%
Revenue estimate 1.875B
Revenue actual 1.88B
Revenue Surprise 0.281%
Dec 31, 2025
$2.77 (0.727%)
Release date Feb 04, 2026
EPS estimate $2.75
EPS actual $2.77
EPS Surprise 0.727%
Revenue estimate 1.647B
Revenue actual 1.649B
Revenue Surprise 0.0865%
Sep 30, 2025
$2.68 (1.90%)
Release date Oct 22, 2025
EPS estimate $2.63
EPS actual $2.68
EPS Surprise 1.90%
Revenue estimate 1.53B
Revenue actual 1.538B
Revenue Surprise 0.491%
Jun 30, 2025
$2.96 (1.72%)
Release date Jul 23, 2025
EPS estimate $2.91
EPS actual $2.96
EPS Surprise 1.72%
Revenue estimate 1.686B
Revenue actual 1.692B
Revenue Surprise 0.385%

Last 4 Quarters for CME Group

Below you can see how CME performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Jun 30, 2025 Beat
Release date Jul 23, 2025
Price on release $276.48
EPS estimate $2.91
EPS actual $2.96
EPS surprise 1.72%
Date Price
Jul 17, 2025 $277.82
Jul 18, 2025 $274.70
Jul 21, 2025 $275.00
Jul 22, 2025 $274.64
Jul 23, 2025 $276.48
Jul 24, 2025 $277.18
Jul 25, 2025 $279.55
Jul 28, 2025 $274.12
Jul 29, 2025 $274.60
4 days before -0.482%
4 days after -0.680%
On release day 0.253%
Change in period -1.16%
Sep 30, 2025 Beat
Release date Oct 22, 2025
Price on release $267.81
EPS estimate $2.63
EPS actual $2.68
EPS surprise 1.90%
Date Price
Oct 16, 2025 $262.51
Oct 17, 2025 $267.94
Oct 20, 2025 $267.62
Oct 21, 2025 $268.61
Oct 22, 2025 $267.81
Oct 23, 2025 $268.90
Oct 24, 2025 $269.54
Oct 27, 2025 $271.09
Oct 28, 2025 $266.33
4 days before 2.02%
4 days after -0.553%
On release day 0.407%
Change in period 1.46%
Dec 31, 2025 Beat
Release date Feb 04, 2026
Price on release $294.62
EPS estimate $2.75
EPS actual $2.77
EPS surprise 0.727%
Date Price
Jan 29, 2026 $289.83
Jan 30, 2026 $289.06
Feb 02, 2026 $290.77
Feb 03, 2026 $293.07
Feb 04, 2026 $294.62
Feb 05, 2026 $297.38
Feb 06, 2026 $302.27
Feb 09, 2026 $307.24
Feb 10, 2026 $306.76
4 days before 1.65%
4 days after 4.12%
On release day 0.94%
Change in period 5.84%
Mar 31, 2026 Beat
Release date Apr 22, 2026
Price on release $285.71
EPS estimate $3.34
EPS actual $3.36
EPS surprise 0.599%
Date Price
Apr 16, 2026 $296.22
Apr 17, 2026 $287.65
Apr 20, 2026 $287.45
Apr 21, 2026 $284.40
Apr 22, 2026 $285.71
Apr 23, 2026 $285.47
Apr 24, 2026 $285.03
Apr 27, 2026 $281.94
Apr 28, 2026 $284.53
4 days before -3.55%
4 days after -0.413%
On release day -0.0840%
Change in period -3.95%

CME Group Earnings Call Transcript Summary of Q1 2026

Key points for investors:

- Record volumes and broad-based growth: CME reported a record Q1 2026 average daily volume (ADV) of 36.2 million contracts, up 22% YoY and the highest quarterly ADV in company history. For the first time CME recorded simultaneous volume records across all six asset classes (rates, equities, energy, ags, metals, FX). Commodity volume rose 38% YoY; financial products volume rose 18%.

- Strong international and client traction: International ADV hit a record 11.4 million contracts (roughly +30% year-over-year) with all regions (EMEA, APAC, LATAM) at record levels. Open interest ended the quarter +11% YoY and +19% since start of 2026; U.S. Treasury open interest reached an all-time high (36.3 million contracts).

- Financial results: Record revenue of $1.9 billion (+14% YoY). Clearing & transaction fees grew 15% YoY; market data revenue was a record $224 million (+15% YoY, marking 32 consecutive quarters of YoY growth). Adjusted operating margin was 72.8% (record); adjusted net income $1.2 billion and adjusted EPS $3.36 (+20% YoY).

- Capital allocation: Returned $3.2 billion to shareholders in Q1 (≈$2.7 billion dividends + $536 million share repurchases). Management described repurchases as opportunistic and noted OSTTRA sale proceeds are being used for buybacks.

- Product, technology and strategic initiatives:

- Regulatory approval for expanded FICC (DTCC) cross-margining to end-user clients (launching 4/30) — expected meaningful collateral/margin efficiencies.

- 24/7 crypto trading planned to go live May 29.

- Filing to convert Micro Equity Index options to financial (cash) settlement to better serve micro-size users.

- Continued cloud migration with a client testing facility in Dallas (on track to open this summer) and planned agricultural product migrations to the cloud by year-end; Google is a strategic cloud partner and its preferred shares converted to common this quarter.

- Tokenization efforts (tokenized cash pilot with Google and banks) targeted to advance testing this year and go-live by year-end; exploring a CME stablecoin subject to regulatory engagement.

- BrokerTec Chicago showing early adoption in U.S. cash treasuries; prediction/event markets ramping (150,000 new accounts, >$220M contract volume since December) with material share of volumes in market-based contracts after FanDuel marketing.

- Business dynamics and headwinds: Rate-per-contract (RPC) was affected by volume tiering, mix shifts (crude vs. nat gas), and strong micro contract growth (micro energy up sharply), which reduces weighted-average RPC despite profitable incremental volume. Management emphasized the benefit of lower pricing tiers to drive incremental, high-margin volume. They also flagged regulatory/legal constraints (e.g., perpetual futures are not permitted under current U.S. law) and continued engagement with regulators on tokenization/stablecoin initiatives.

- Management view: Confident in continued client-driven growth, capital efficiency gains for customers (management cited ~$85B/day of margin savings currently) and disciplined capital allocation while remaining open to sensible M&A if it benefits shareholders.

CME Group Earnings History

Earnings Calendar

FAQ

When is the earnings report for CME?
CME Group Inc. (CME) has scheduled its earnings report for Jul 22, 2026 before the markets open.

What is the CME price-to-earnings (P/E) ratio?
CME P/E ratio as of Jun 12, 2026 (TTM) is 22.83.

What is the CME EPS forecast?
The forecasted EPS (Earnings Per Share) for CME Group Inc. (CME) for the first fiscal quarter 2026 is $3.01.

What are CME Group Inc.'s retained earnings?
On its balance sheet, CME Group Inc. reported retained earnings of $1.88 billion for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT CME GROUP INC.
CME Group
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE